Ouseph A K, Levine J D
Department of Anatomy, University of California, San Francisco 94143-0452, USA.
Eur J Pharmacol. 1995 Jan 24;273(1-2):107-12. doi: 10.1016/0014-2999(94)00677-y.
The model of rolipram (a type IV phosphodiesterase inhibitor) induced prolongation (> 3 days) of the mechanical hyperalgesia produced by the intradermal injection of prostaglandin E2 in the hairy skin of the hindpaw of the rat, measured by the Randall-Selitto paw-withdrawal test, was employed to study mechanisms involved in the contribution of the sympathetic postganglionic neuron to mechanical hyperalgesia. Lumbar surgical sympathectomy prevented rolipram-induced prolongation of prostaglandin E2 hyperalgesia. Decentralization of sympathetic postganglionic neurons innervating the hindpaw did not, however, effect rolipram-induced prolongation of prostaglandin E2 hyperalgesia. Phentolamine, an alpha-adrenoceptor antagonist, and prazosin, an alpha 1-selective adrenoceptor antagonist, when given systemically or intradermally at the site of injection of prostaglandin E2 and rolipram, blocked rolipram-induced prolongation of prostaglandin E2 hyperalgesia. Intrathecal administration of phentolamine and prazosin were, however, without effect on rolipram-induced prolongation of prostaglandin E2 hyperalgesia. Yohimbine, an alpha 2-adrenoceptor antagonist given systemically, intradermally or intrathecally also did not produce any alteration in rolipram-induced prolongation of prostaglandin E2 hyperalgesia. We propose that sympathetic postganglionic neurons are involved in rolipram-induced prolongation of prostaglandin E2 hyperalgesia and that this form of sympathetically dependent hyperalgesia, which is independent of activity in preganglionic sympathetic neurons, is mediated by a peripheral alpha 1-adrenergic mechanism.
采用咯利普兰(一种IV型磷酸二酯酶抑制剂)诱导大鼠后爪毛状皮肤皮内注射前列腺素E2所产生的机械性痛觉过敏延长(>3天)的模型(通过Randall-Selitto paw-withdrawal试验测量),来研究交感神经节后神经元对机械性痛觉过敏作用的相关机制。腰部手术切除交感神经可防止咯利普兰诱导的前列腺素E2痛觉过敏延长。然而,支配后爪的交感神经节后神经元去传入并没有影响咯利普兰诱导的前列腺素E2痛觉过敏延长。酚妥拉明(一种α-肾上腺素能受体拮抗剂)和哌唑嗪(一种α1选择性肾上腺素能受体拮抗剂),当全身给药或在注射前列腺素E2和咯利普兰的部位皮内给药时,可阻断咯利普兰诱导的前列腺素E2痛觉过敏延长。然而,鞘内注射酚妥拉明和哌唑嗪对咯利普兰诱导的前列腺素E2痛觉过敏延长没有影响。育亨宾(一种α2-肾上腺素能受体拮抗剂)全身、皮内或鞘内给药也不会对咯利普兰诱导的前列腺素E2痛觉过敏延长产生任何改变。我们提出交感神经节后神经元参与咯利普兰诱导的前列腺素E2痛觉过敏延长,并且这种形式的交感神经依赖性痛觉过敏独立于节前交感神经元的活动,是由外周α1-肾上腺素能机制介导的。